VERTEX PHARMACEUTICALS INC / MA (VRTX)
Clinical trial NCT06154447 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-16 → 2026-07-10 3. primary completion date: 2026-07-16 → 2026-07-10
Clinical trial NCT06154447 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-16 → 2026-07-10 3. primary completion date: 2026-07-16 → 2026-07-10
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical